APA (7th ed.) Citation

J, G., M, S., S, Y., N, K., AL, T., ME, M., . . . KC, P. (2026). Clinical relevance of transcriptome profiling for assessing prognosis, platinum insensitivity, and precision therapeutics in endometrial cancer. Gynecologic oncology, 210, 114. https://doi.org/10.1016/j.ygyno.2026.05.021

Chicago Style (17th ed.) Citation

J, Gonzalez-Bosquet, et al. "Clinical Relevance of Transcriptome Profiling for Assessing Prognosis, Platinum Insensitivity, and Precision Therapeutics in Endometrial Cancer." Gynecologic Oncology 210 (2026): 114. https://doi.org/10.1016/j.ygyno.2026.05.021.

MLA (9th ed.) Citation

J, Gonzalez-Bosquet, et al. "Clinical Relevance of Transcriptome Profiling for Assessing Prognosis, Platinum Insensitivity, and Precision Therapeutics in Endometrial Cancer." Gynecologic Oncology, vol. 210, 2026, p. 114, https://doi.org/10.1016/j.ygyno.2026.05.021.